In this article, we deep dive into the 5 stocks with insane returns on Wednesday. For a deeper discussion and an extended list, please see 10 Stocks With Insane Returns Right Now.
Photo by Mizuno K on Pexels
5. Astera Labs Inc. (NASDAQ:ALAB)
Astera Labs rallied for a second day on Wednesday to notch a new all-time high, as investors resumed buying positions after an investment firm assigned a bullish stance on its stock.
Earlier in the week, Evercore ISI issued an outperform rating and a $297 price target for shares of Astera Labs Inc. (NASDAQ:ALAB), boosting optimism and helping propel its actual share price to as much as $287.70 during the day—its highest on record. It trimmed a few cents toward the end of the session to finish up by 17.69 percent at $287.48 apiece.
Investors also loaded portfolios following CEO Jitendra Mohan’s participation at the JPMorgan annual Global Technology, Media and Communications Conference, where he presented Astera Labs Inc.’s (NASDAQ:ALAB) newest AI data center networking solutions.
On May 27, the company would also partake in the 54th Annual Technology, Media & Telecom Conference by TD Cowen in New York, as well as the 2026 Evercore Global TMT Conference in San Francisco on June 3.
In other news, the company earlier this month unveiled a new memory-semantic fabric switch called the Scorpio X-Series 320 Lane, designed to improve token economics and support large-scale clusters with minimal latency.
According to Astera Labs Inc. (NASDAQ:ALAB), Scorpio’s software-defined architecture is designed to integrate seamlessly with leading merchant and custom silicon, enabling AI labs and hyperscalers to integrate and deploy new accelerator platforms for both training and inference.
4. Navitas Semiconductor Corp. (NASDAQ:NVTS)
Navitas Semiconductor snapped a three-day losing streak on Wednesday, soaring 18.32 percent to close at $22.99 apiece as investors loaded portfolios ahead of its participation in a conference.
In a notice on its website, Navitas Semiconductor Corp. (NASDAQ:NVTS) said that it would participate in the PCIM 2026 in Nuremberg, Germany, for the entire three-day event, mainly focusing on key areas such as automotive, AI, humanoid robots, the evolution in data center power distribution, riding the SiC wave efficiently, and the future of GaN.
It will also showcase its latest gallium nitride (GaN) and GeneSiC silicon carbide (SiC) power semiconductors catered to the needs of AI data centers, energy and grid infrastructure, and industrial electrification.
Navitas Semiconductor Corp. (NASDAQ:NVTS) said that it will specifically exhibit two solutions that enable a swifter transition to the 800 VDC standard using GaN, as well as two SST topologies enabled by Navitas GeneSiC UHV and HV technology.
In other news, Navitas Semiconductor Corp. (NASDAQ:NVTS) more-than-doubled its net loss in the first quarter of the year to $33.78 million from $16.8 million in the same period last year. Net revenues also declined by 38 percent to $8.6 million from $14 million year-on-year.
3. Xanadu Quantum Technologies Ltd. (NASDAQ:XNDU)
Xanadu snapped a three-day losing streak on Wednesday, surging by 20.56 percent to close at $14.13 apiece, as investors resorted to bargain-hunting, supported by continued optimism for the photonics sector.
Since the start of the month, Xanadu Quantum Technologies Ltd. (NASDAQ:XNDU) has already seen its share price drop by as much as 59 percent, dragged by a 68.8 percent deeper net loss in the first quarter of the year, at $20.6 million versus $12.2 million in the same period last year.
Revenues, on the other hand, increased by 305 percent to $2.832 billion from $699 million year-on-year.
Further weighing in on investor sentiment was news last week that it would issue new shares through an at-the-market facility offering in support of plans to raise $300 million in fresh funds, proceeds of which will be used to fund the continued development of its quantum computing technology roadmap.
Xanadu Quantum Technologies Ltd. (NASDAQ:XNDU) is a newly listed company that only went public on March 23 through a merger with Crane Harbor Acquisition Corp., a special purpose acquisition company. Its systems and software are used by various industries, including defense, aerospace, pharmaceuticals, semiconductors, and automotive sectors, among others.
2. T1 Energy Inc. (NYSE:TE)
T1 Energy soared by 26.45 percent on Wednesday to close at $8.70 apiece, as investors took heart from an investment firm’s strong optimism for the stock, after getting battered by a short seller, which claimed that it is not eligible for US tax credits.
In a market note, Roth Capital recommended investors take the sell-off as a buying opportunity, saying that T1 Energy Inc. (NYSE:TE) is a “model for what the Trump administration may want in a domestic manufacturer that is transferring advanced technology and capacity to the US.”
Earlier in the week, T1 Energy Inc. (NYSE:TE) was hit by a short seller report by Fuzzy Panda, saying that the company was not compliant with the foreign entity of concern (FEOC) regulations, and thus not eligible for tax credits from the US government.
The report said that T1 Energy Inc.’s (NYSE:TE) sale of intellectual property to Singaporean firm Evervolt was designed to achieve FEOC compliance, but that the latter had undisclosed connections with Chinese solar firm Trina Solar.
Fuzzy Panda claimed that Evervolt, owned by Tan Chin Piaw, has maintained business relationships with Trina Solar for more than 15 years, and that 99 percent of its revenues came from the latter.
1. Immunovant Inc. (NASDAQ:IMVT)
Immunovant saw its share prices soar to a new five-year high on Wednesday, as investors took heart from the stellar results of its clinical trial to study its drug candidate for hard-to-treat rheumatoid arthritis.
In an updated report, Immunovant Inc. (NASDAQ:IMVT) said that its treatment candidate, IMVT-1402, showed clinically meaningful response rates of 72.7 percent ACR20, 54.5 percent ACR50, and 35.8 percent ACR70 at Week 16.
Immunovant Inc. (NASDAQ:IMVT) said that it would announce further updates on the program in the second half of 2026.
Following the results, the company’s shares climbed to their highest price of $36.28 before paring gains to end the session just up by 35.26 percent at $35.56 apiece.
In other news, investment firm Stifel reiterated its “buy” recommendation and $49 price target for Immunovant Inc. (NASDAQ:IMVT), reflecting its confidence that the results would soon progress to the regulatory approval stage and commercial launch.
The biopharmaceutical company also reported its earnings performance in the first quarter of the year, with net losses widening by 38.9 percent to $147.8 million from $106.4 million in the same period last year.
While we acknowledge the potential of IMVT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IMVT and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.
